Conference Call to Update Shareholders on Important Developments - Monday
BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it will hold a conference call on Monday, April 28, 2014 at 8:45 a.m. Eastern Daylight Time (EDT), 15:45 Israel Daylight Time (IDT). Mr. Chaim Lebovits, BrainStorm's President and Principal Executive Officer, will provide an update to shareholders and discuss important company developments.
Sounds like they have a few things to talk about. Crossing my fingers that they will finally announce IND approval. It would also be great if they also announced that they had all of their review boards in place and that the trials would commence in the very near future. Probably wishful thinking on my part, but they have certainly had enough time to get all of their ducks in a row (and have indicated that they have).